| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cognetivity Neurosciences Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.015 |
| 52 Week High | CA$0.37 |
| 52 Week Low | CA$0.01 |
| Beta | -0.38 |
| 1 Month Change | 0% |
| 3 Month Change | -25.00% |
| 1 Year Change | -95.89% |
| 3 Year Change | -97.12% |
| 5 Year Change | -96.00% |
| Change since IPO | -94.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| CGN | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | -25.0% | 1.7% | -1.5% |
| 1Y | -95.9% | -24.7% | 4.7% |
Return vs Industry: CGN underperformed the Canadian Medical Equipment industry which returned -24.7% over the past year.
Return vs Market: CGN underperformed the Canadian Market which returned 4.7% over the past year.
Price Volatility
| CGN volatility | |
|---|---|
| CGN Average Weekly Movement | 47.3% |
| Medical Equipment Industry Average Movement | 11.8% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.4% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: CGN's share price has been volatile over the past 3 months.
Volatility Over Time: CGN's weekly volatility has increased from 34% to 47% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Sina Habibi | cognetivity.com |
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. Fundamentals Summary
| CGN fundamental statistics | |
|---|---|
| Market cap | CA$2.34m |
| Earnings (TTM) | -CA$8.64m |
| Revenue (TTM) | CA$98.97k |
14.2x
P/S Ratio-0.2x
P/E RatioIs CGN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CGN income statement (TTM) | |
|---|---|
| Revenue | CA$98.97k |
| Cost of Revenue | CA$1.36m |
| Gross Profit | -CA$1.27m |
| Other Expenses | CA$7.38m |
| Earnings | -CA$8.64m |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.092 |
| Gross Margin | -1,278.71% |
| Net Profit Margin | -8,732.77% |
| Debt/Equity Ratio | -19.9% |
How did CGN perform over the long term?
See historical performance and comparison